Blog
CaliberCos (CWD) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Wednesday, August 13, 2025 at 5 p.m. ET
Chief Executive Officer — Chris Loeffler
Source Fool.com
Enliven Posts Loss Beat and Cash Surge
Enliven Therapeutics (NASDAQ:ELVN), a clinical-stage biotechnology company focused on cancer therapies, reported its second quarter 2025 results on August 13, 2025. The release highlighted a net
Dyadic International Narrows Q2 Loss
Dyadic International (NASDAQ:DYAI) reported Q2 2025 earnings on August 13, 2025, delivering GAAP revenue of $967,000, representing a year-over-year increase over Q2 2024 and the company’s clearest
Applied Therapeutics Reports Q2 Loss
Applied Therapeutics (NASDAQ:APLT), a biotechnology company focused on developing treatments for rare metabolic diseases, reported earnings results for Q2 2025 on August 13, 2025. The main news from
Ibotta Posts 2 Percent Sales Decline
Ibotta (NYSE:IBTA), a leading digital promotions and performance marketing platform for consumer packaged goods (CPG), released financial results for Q2 2025 on August 13, 2025. The most notable
Allogene Q2 Cash Tops $300 Million
Allogene Therapeutics (NASDAQ:ALLO) reported second-quarter 2025 results on August 13, 2025, highlighting $302.6 million in cash and investments as of the end of Q2 2025 with a projected cash runway
Dyadic (DYAI) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Wednesday, August 13, 2025 at 5:00 p.m. ET
President and Chief Operating Officer — Joe Hazelton
Source Fool.com
Natural Gas Services Group Beats Q2 EPS
Natural Gas Services Group (NYSE:NGS), a provider of natural gas compression equipment rentals and services, Natural Gas Services Group released its financial results for Q2 FY2025 on August 11
Acrivon Posts Narrower Loss in Q2
Acrivon Therapeutics (NASDAQ:ACRV), a clinical-stage biotech developing precision oncology medicines, released its second quarter 2025 results on August 13, 2025. The report showed a GAAP net loss
Spire Global Posts Debt Free Q2 Results
Spire Global (NYSE:SPIR) reported preliminary Q2 2025 GAAP revenue of $18 million to $19 million, following the transformative sale of its maritime business and full elimination of company debt
Dolphin Revenue Jumps 23 Percent
Dolphin Entertainment (NASDAQ:DLPN), a diversified entertainment marketing and content production company, released its second quarter 2025 results on August 13, 2025. The headline news was a record
Oncology Institute TOI Earnings Call Transcript
Image source: The Motley Fool.
Aug. 13, 2025 at 5 p.m. ET
Chief Executive Officer — Daniel Virnich
Source Fool.com
Tenax Posts Wider Loss in Fiscal Q2
Tenax Therapeutics (NASDAQ:TENX), a development-stage biopharmaceutical company focused on treatments for cardiovascular and pulmonary diseases, released its results for the second quarter of fiscal
SurgePays Lifeline Activations Jump
SurgePays (NASDAQ:SURG) reported its fiscal Q2 2025 earnings on August 5, 2025 (for the quarter ended June 30, 2025), with revenue rose 8.9% quarter over quarter to $11.5 million and issued revenue
Aterian Q2 Revenue Falls 30 Percent
Aterian (NASDAQ:ATER) reported Q2 2025 results on August 13, revealing a 30.5% year-over-year decrease in net revenue to $19.5 million and a swing to a $2.2 million adjusted EBITDA loss from a
Why eToro Group Stock Swooned on Wednesday
Next-generation fintech eToro Group (NASDAQ: ETOR) was looking like quite the tired animal on the stock market Wednesday. For the third trading session in a row its shares closed the day lower in
Dolphin (DLPN) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Wednesday, August 13, 2025 at 4:30 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Marpai Cuts Losses as Expenses Drop 70%
Marpai (OTC:MRAI), a third-party health plan administrator, released its earnings for the second quarter of 2025 on August 13, 2025. The company reported net revenue declined to $4.7 million, down
The Oncology Institute Q2 Revenue Surges
The Oncology Institute (NASDAQ:TOI) reported fiscal second quarter ended June 30, 2025, earnings on August 13, 2025, posting 21.5% year-over-year revenue growth to $119.8 million. Pharmacy revenue
Fossil (FOSL) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Fossil(NASDAQ:FOSL) held its second quarter 2025 earnings call to discuss financial results, operational highlights, and strategic updates.
Wednesday, August 13, 2025
Fossil Posts Narrower Loss in Q2
Fossil Group (NASDAQ:FOSL), known for its portfolio of fashion watches and accessories, reported its latest quarterly results on Aug. 13, 2025. The most notable news in the release was a
Fossil Group Lifts Outlook on Q2 Profit
Fossil Group(NASDAQ:FOSL) reported results for the second quarter of 2025 on August 13, surpassing expectations with adjusted operating income of $4 million, gross margin of 57.4%, and cost
Motorsport Games (MSGM) Earnings Transcript
Image source: The Motley Fool.
Wednesday, Aug. 13, 2025 at 5 p.m. ET
Chief Executive Officer — Stephen Hood
Source Fool.com
STRATA Skin Sciences Eyes Market Growth
STRATA Skin Sciences(NASDAQ:SSKN) reported its second-quarter 2025 results on August 13, 2025, highlighting significant developments in reimbursement expansion, ongoing litigation, and commercial
Dyadic Revenue Jumps 150% in Fiscal Q2
Dyadic International (NASDAQ:DYAI), a biotechnology company focused on protein and enzyme production through its unique microbial platforms, reported its second quarter 2025 results on August 13